A Study to Assess the Safety and Efficacy of Vatiquinone in Participants With Friedreich Ataxia (NCT05515536)

🧪 Interventions in This Study

• Vatiquinone (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (14 Sites)

• UCLA — Los Angeles, California
• University of Florida — Gainesville, Florida
• University of South Florida — Tampa, Florida
• University of Iowa — Iowa City, Iowa
• The Children's Hospital of Philadelphia — Philadelphia, Pennsylvania
• Murdoch Children's Research Institute — Parkville, Victoria
• University of Campinas (UNICAMP) - School of Medical Sciences, Dept of Neurology — São Paulo,
• Centre de Recherche du Centre Hospitalier de l'Université de Montreal (CRCHUM) — Montreal, Quebec
• CHU Sainte-Justine — Montreal, Quebec
• Hôpital Pitié-Salpêtrière, Institut du Cerveau (Paris Brain Institute) — Paris,
• Department of Neurology and Hertie-Institute for Clinical Brain Research German Center of Neurodegenerative Diseases (DZNE) — Tübingen,
• Ospedale Pediatrico Bambino Gesu' IRCCS — Roma,
• CBR Neurogenetic Research Clinic, University of Auckland — Auckland,
• Hospital Sant Joan de Déu Barcelona Unidad de Enfermedades Neuromusculares — Barcelona,

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Friedreich Ataxia

• A Study to Find Out How BIIB141 (Omaveloxolone) is Processed in the Body and to Learn More About Its Safety in Participants With Friedreich's Ataxia Aged 2 to 15 Years Old — Philadelphia, Pennsylvania
• A Natural History Study to TRACK Brain and Spinal Cord Changes in Individuals with Friedreich Ataxia (TRACK-FA) — Gainesville, Florida
• FA Clinical Outcome Measures — Los Angeles, California
• Gene Therapy for Cardiomyopathy Associated With Friedreich's Ataxia — Los Angeles, California
• Clinical Course Of Disease In Participants With FA-CM — La Jolla, California

Explore by condition: All Friedreich Ataxia clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.